APA (7th ed.) Citation

Knödler, M., Gauler, T. C., Gruenwald, V., Matzdorff, A., Schroeder, M., Dietz, A., . . . Keilholz, U. (2013). Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy: A multicenter study of the Arbeitsgemeinschaft Internistische Onkologie. Oncology, 84(5), . https://doi.org/10.1159/000345453

Chicago Style (17th ed.) Citation

Knödler, Michael, et al. "Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck After Platinum-containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie." Oncology 84, no. 5 (2013). https://doi.org/10.1159/000345453.

MLA (9th ed.) Citation

Knödler, Michael, et al. "Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck After Platinum-containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie." Oncology, vol. 84, no. 5, 2013, https://doi.org/10.1159/000345453.